NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Doc Logic,

Thank you! First of all, I apologize i forgot the link in my post: https://www.izi.fraunhofer.de/content/dam/izi/de/documents/Publikationen/Fraunhofer_IZI_Jahresbericht_2017.pdf

You say:” What should be noted here is that the number of patients statistically necessary to prove statistical significance drops in proportion to treatment effectiveness. So when saying "statistically necessary" they are talking about the number of patients needed to prove effect not necessarily the total number of patients originally planned for enrollment to prove what might have been a lesser planned for effect.”

100% agree,after i read the article again.(“ Die Rekrutierung der für die Studie statistisch notwendigen Patientenzahl wurde bereits im Jahr 2015 abgeschlossen und damit die Herstellungs- und Prüftätigkeiten an Fraunhofer IZI erfolgreich beendet”)

It’s also important to note that manufacturing and testing activities were successfully completed!

And at the end of the article they say this: “Dieser Prozess wird sich auch im Jahr 2018 bis zum Versand der letzten vorgesehenen Dosierung fortsetzen. Danach ist die Auswertung der klinischen Studie durch den Sponsor Northwest Biotherapeutics Inc. zu erwarten.” (Google translation:” This process will continue in 2018 until the last scheduled dosage is shipped. Thereafter, evaluation of the clinical trial by sponsor Northwest Biotherapeutics Inc. is expected.")

I think that means there was no data lock in 2017 but it can happen any time in 2018.(If i’m right about the protocol:no more Dcvax-L for the patiënt after data lock.)
Do logic in post 167444 you write: “The wild cards appear to October 2017 meeting in Canada……” https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140050303

I think you mean 16-17 October 2017 DCVAX-Monitor meeting!
https://neuromedia.mcgill.ca/mnibooking/report.php

Name: Lisa Nezvitsky
Department Head: Dr. Genge
Meeting Name: CRU Monitor

This one is a guess but i have good reason to believe there was a lot of activity end of Jan.2018 - beginning of Feb.2018 in Canada about the same data!( with Lisa Nezvitsky the person in charge of the DCVAX-L trial in Canada)

Have a nice weekend!